Jennifer A. Woyach, MD

Professor of Medicine
Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center

Poster(s):

• 1439 - Ten-year follow-up of a phase II study of ibrutinib in relapsed/ refractory chronic lymphocytic leukemia (CLL)/ small lymphocytic lymphoma (SLL)

• 1440 - Transcriptional reprogramming and survival co-dependencies of chronic lymphocytic leukemia resistant to venetoclax

• 1524 - Patient-Reported Outcomes (PRO) among Patients with Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) receiving Pirtobrutinib: Final Analysis from the BRUIN Phase 1/2 Study

• 1801 - Targeting BTKi-Resistant CLL Using the Dual Irreversible/Reversible 4th Generation BTK Inhibitor Rocbrutinib